Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

CTI Biopharma

CTI Biopharma reported $-9232000 in Operating Profit for its fiscal quarter ending in March of 2023.

Operating Profit Change
Baxter International BAX:US USD 186M 5M
Bristol-Myers Squibb BMY:US USD 3.1B 1.15B
CTI Biopharma CTIC:US USD -9232000 4.36M
Eli Lilly LLY:US USD 1.49B 342.4M
Geron GERN:US USD -40092000 1.86M
Incyte Corp INCY:US USD 24.77M 45.32M
Mirati Therapeutics MRTX:US USD -193823000 17.9M
Northwest Biotherapeutics NWBO:US USD -14372000 6.34M
Novartis NOVN:VX USD 2.86B 907M
Novartis NVS:US USD 2.86B 907M
Plus Therapeutics, Inc. CYTX:US USD -4720000 852K
Seattle Genetics SGEN:US USD -184513000 30.51M